Epidermal growth factor-genistein
Alternative Names: EGF-genistein; Epidermal growth factor-genistein conjugateLatest Information Update: 04 Oct 2006
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action Epidermal growth factor receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Coronary artery restenosis; Vascular restenosis
Most Recent Events
- 04 Oct 2006 Discontinued - Preclinical for Coronary artery restenosis in USA (unspecified route)
- 04 Oct 2006 Discontinued - Preclinical for Vascular restenosis in USA (unspecified route)
- 16 May 2000 New profile